Literature DB >> 19965706

Mining ferritin iron: 2 pathways.

Elizabeth C Theil1.   

Abstract

Entities:  

Year:  2009        PMID： 19965706     DOI： 10.1182/blood-2009-08-239913

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Specific hemosiderin deposition in spleen induced by a low dose of cisplatin: altered iron metabolism and its implication as an acute hemosiderin formation model.

Authors:  Yingze Wang; L V Juan; Xiaowei Ma; Dongliang Wang; Huili Ma; Yanzhong Chang; Guangjun Nie; Lee Jia; Xianglin Duan; Xing-Jie Liang
Journal:  Curr Drug Metab       Date:  2010-07       Impact factor: 3.731

3.  Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.

Authors:  Zhi Liu; Tien-Min Lin; Max Purro; May P Xiong
Journal:  ACS Appl Mater Interfaces       Date:  2016-09-26       Impact factor: 9.229

4.  Nanogel-DFO conjugates as a model to investigate pharmacokinetics, biodistribution, and iron chelation in vivo.

Authors:  Yan Wang; Zhi Liu; Tien-Min Lin; Shaurya Chanana; May P Xiong
Journal:  Int J Pharm       Date:  2018-01-16       Impact factor: 5.875

5.  HIF-1 regulates iron homeostasis in Caenorhabditis elegans by activation and inhibition of genes involved in iron uptake and storage.

Authors:  Steven Joshua Romney; Ben S Newman; Colin Thacker; Elizabeth A Leibold
Journal:  PLoS Genet       Date:  2011-12-15       Impact factor: 5.917

Review 6.  Iron homeostasis in host and gut bacteria - a complex interrelationship.

Authors:  Yohannes Seyoum; Kaleab Baye; Christèle Humblot
Journal:  Gut Microbes       Date:  2021 Jan-Dec

7.  Model-Based Optimisation of Deferoxamine Chelation Therapy.

Authors:  Francesco Bellanti; Giovanni C Del Vecchio; Maria C Putti; Carlo Cosmi; Ilaria Fotzi; Suruchi D Bakshi; Meindert Danhof; Oscar Della Pasqua
Journal:  Pharm Res       Date:  2015-11-10       Impact factor: 4.200
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.